These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 8880225

  • 1. Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro.
    Kurakata S, Kada M, Shimada Y, Komai T, Nomoto K.
    Immunopharmacology; 1996 Aug; 34(1):51-61. PubMed ID: 8880225
    [Abstract] [Full Text] [Related]

  • 2. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH, van Vliet A, Roodenburg L, Jansen LM, Griffioen M.
    Biochem Pharmacol; 1993 Jun 09; 45(11):2203-8. PubMed ID: 8517861
    [Abstract] [Full Text] [Related]

  • 3. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes.
    Masters BA, Palmoski MJ, Flint OP, Gregg RE, Wang-Iverson D, Durham SK.
    Toxicol Appl Pharmacol; 1995 Mar 09; 131(1):163-74. PubMed ID: 7878672
    [Abstract] [Full Text] [Related]

  • 4. Action of lovastatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle.
    van Vliet AK, Nègre-Aminou P, van Thiel GC, Bolhuis PA, Cohen LH.
    Biochem Pharmacol; 1996 Nov 08; 52(9):1387-92. PubMed ID: 8937448
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Aoki T, Nishimura H, Nakagawa S, Kojima J, Suzuki H, Tamaki T, Wada Y, Yokoo N, Sato F, Kimata H, Kitahara M, Toyoda K, Sakashita M, Saito Y.
    Arzneimittelforschung; 1997 Aug 08; 47(8):904-9. PubMed ID: 9296275
    [Abstract] [Full Text] [Related]

  • 6. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens.
    Mosley ST, Kalinowski SS, Schafer BL, Tanaka RD.
    J Lipid Res; 1989 Sep 08; 30(9):1411-20. PubMed ID: 2513368
    [Abstract] [Full Text] [Related]

  • 7. Tissue-selective inhibition of sterol synthesis in mice by pravastatin sodium after a single or repeated oral administrations.
    Koga T, Kikuchi T, Miyazaki A, Koike H.
    Lipids; 1995 Aug 08; 30(8):775-9. PubMed ID: 7475995
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors.
    Newman A, Clutterbuck RD, Powles RL, Catovsky D, Millar JL.
    Leuk Lymphoma; 1997 Feb 08; 24(5-6):533-7. PubMed ID: 9086443
    [Abstract] [Full Text] [Related]

  • 9. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin.
    Serajuddin AT, Ranadive SA, Mahoney EM.
    J Pharm Sci; 1991 Sep 08; 80(9):830-4. PubMed ID: 1800703
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of cholesterol synthesis and hepatic 3-hydroxy-3-methylglutaryl--CoA reductase in rats by simvastatin and pravastatin.
    Del Puppo M, Rauli S, Galli Kienle M.
    Lipids; 1995 Nov 08; 30(11):1057-61. PubMed ID: 8569435
    [Abstract] [Full Text] [Related]

  • 11. [Effect of the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme-A reductase, pravastatin and simvastatin, on colony formation by hematopoietic progenitor cells].
    Kunitama M, Komatsu N, Miura Y.
    Rinsho Ketsueki; 1996 Nov 08; 37(11):1314-7. PubMed ID: 8960668
    [Abstract] [Full Text] [Related]

  • 12. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein.
    Sakai M, Kobori S, Matsumura T, Biwa T, Sato Y, Takemura T, Hakamata H, Horiuchi S, Shichiri M.
    Atherosclerosis; 1997 Aug 08; 133(1):51-9. PubMed ID: 9258407
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types.
    Nègre-Aminou P, van Vliet AK, van Erck M, van Thiel GC, van Leeuwen RE, Cohen LH.
    Biochim Biophys Acta; 1997 Apr 21; 1345(3):259-68. PubMed ID: 9150246
    [Abstract] [Full Text] [Related]

  • 14. Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types.
    van Vliet AK, van Thiel GC, Huisman RH, Moshage H, Yap SH, Cohen LH.
    Biochim Biophys Acta; 1995 Jan 03; 1254(1):105-11. PubMed ID: 7811739
    [Abstract] [Full Text] [Related]

  • 15. Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by lovastatin.
    Cutts JL, Bankhurst AD.
    Int J Immunopharmacol; 1989 Jan 03; 11(8):863-9. PubMed ID: 2515162
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733).
    Hidaka Y, Eda T, Yonemoto M, Kamei T.
    Atherosclerosis; 1992 Jul 03; 95(1):87-94. PubMed ID: 1642695
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I, Spinler SA, Johnson NE.
    Ann Pharmacother; 1995 Jul 03; 29(7-8):743-59. PubMed ID: 8520093
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H, Fager G.
    Clin Pharmacokinet; 1997 May 03; 32(5):403-25. PubMed ID: 9160173
    [Abstract] [Full Text] [Related]

  • 19. Effects of HMG-CoA reductase inhibitors on growth and differentiation of cultured rat skeletal muscle cells.
    Veerkamp JH, Smit JW, Benders AA, Oosterhof A.
    Biochim Biophys Acta; 1996 Apr 12; 1315(3):217-22. PubMed ID: 8611662
    [Abstract] [Full Text] [Related]

  • 20. Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat.
    Koga T, Fukuda K, Shimada Y, Fukami M, Koike H, Tsujita Y.
    Eur J Biochem; 1992 Oct 01; 209(1):315-9. PubMed ID: 1396707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.